Models for studying coronary artery stenting

Drug Discovery Today: Disease Models

Volumn 3, Issue 3, 2006, Pages 297-303

  Alp, Nicholas J ^a   Ali, Ziad A ^a   Channon, Keith M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; COBALT; DACTINOMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NICKEL; PACLITAXEL; POLYLACTIC ACID; RAPAMYCIN; STAINLESS STEEL; TITANIUM;

ARTERY INTIMA PROLIFERATION; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; BIOPHYSICS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DISEASE EXACERBATION; DRUG ELUTING STENT; EXPERIMENTAL MODEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL COMPUTING; NONHUMAN; POSTOPERATIVE THROMBOSIS; RESTENOSIS; REVIEW; SYMPTOMATOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR PATENCY;

EID: 33751220506     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.10.001     Document Type: Review

References (50)

1. Biondi-Zoccai G.G., et al. Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression. Am. Heart. J. 149 (2005) 504-511
2. Nakamura S., et al. Intracoronary ultrasound observations during stent implantation. Circulation 89 (1994) 2026-2034
3. Kereiakes D.J., et al. Usefulness of a cobalt chromium coronary stent alloy. Am. J. Cardiol. 92 (2003) 463-466
4. Stoeckel D., et al. Self-expanding nitinol stents: material and design considerations. Eur. Radiol. 14 (2004) 292-301
5. Peuster M., et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart 86 (2001) 563-569
6. Di Mario C., et al. Drug-eluting bioabsorbable magnesium stent. J. Interv. Cardiol. 17 (2004) 391-395
7. Lafont A., et al. PLA stereocopolymers as sources of bioresorbable stents: preliminary investigation in rabbit. J. Biomed. Mater. Res. B Appl. Biomater. 77 (2006) 349-356
8. Malik N., et al. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility. J. Invasive Cardiol. 13 (2001) 193-201
9. Burt H.M., et al. Drug-eluting stents: a multidisciplinary success story. Adv. Drug. Deliv. Rev. 58 (2006) 350-357
10. Finkelstein A., et al. Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 107 (2003) 777-784
11. Prasad C.K., et al. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents. J. Biomater. Appl. 19 (2005) 271-286
12. Nebeker J.R., et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J. Am. Coll. Cardiol. 47 (2006) 175-181
13. Kalmar G., et al. Radial force and wall apposition of balloon-expandable vascular stents in eccentric stenoses: an in vitro evaluation in a curved vessel model. J. Vasc. Interv. Radiol. 13 (2002) 499-508
14. Poerner T.C., et al. Determinants of stent expansion in curved stenotic lesions: an in vitro experimental study. J. Vasc. Interv. Radiol. 15 (2004) 727-735
15. Gunn J., et al. Coronary artery stretch versus deep injury in the development of in-stent neointima. Heart 88 (2002) 401-405
16. Narracott A.J., et al. Measurement of the symmetry of in vitro stent expansion: a stereo-photogrammetric approach. J. Med. Eng. Technol. 27 (2003) 59-70
17. Benard N., et al. Experimental study of laminar blood flow through an artery treated by a stent implantation: characterisation of intra-stent wall shear stress. J. Biomech. 36 (2003) 991-998
18. Seo T., et al. Computational study of fluid mechanical disturbance induced by endovascular stents. Ann. Biomed. Eng. 33 (2005) 444-456
19. Eto K., et al. Two distinct mechanisms are involved in stent thrombosis under flow conditions. Platelets 12 (2001) 228-235
20. Tepe G., et al. Thrombogenicity of various endovascular stent types: an in vitro evaluation. J. Vasc. Interv. Radiol. 13 (2002) 1029-1035
21. Hamuro M., et al. Influence of stent edge angle on endothelialization in an in vitro model. J. Vasc. Interv. Radiol. 12 (2001) 607-611
22. Sprague E.A., et al. Human aortic endothelial cell migration onto stent surfaces under static and flow conditions. J. Vasc. Interv. Radiol. 8 1 Pt 1 (1997) 83-92
23. Clowes A.W., et al. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56 (1985) 139-145
24. Powell J.S., et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245 (1989) 186-188
25. Berger P.B., et al. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the multicenter american research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (MARCATOR). J. Am. Coll. Cardiol. 27 (1996) 1-7
26. Kanamasa K., et al. A 7-day administration of tPA or heparin in the prevention of intimal hyperplasia following vascular injury in atherosclerotic rabbits. J. Interv. Cardiol. 15 (2002) 191-195
27. Schwartz R.S., Chronos N.A., and Virmani R. Preclinical restenosis models and drug-eluting stents: Still important, still much to learn. J. Am. College Cardiol. 44 (2004) 1373-1385
28. Serruys P.W., et al. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J. Am. Coll. Cardiol. 44 (2004) 1363-1367
29. Roubin G.S., et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation 76 (1987) 891-897
30. Schwartz R.S., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J. Am. Coll. Cardiol. 19 (1992) 267-274
31. Rapacz J., et al. Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Science 234 (1986) 1573-1577
32. Lowe H.C., et al. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc. Interv. 60 (2003) 515-523
33. Carter A.J., et al. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J. Am. Coll. Cardiol. 24 (1994) 1398-1405
34. Virmani R., et al. Drug eluting stents: are human and animal studies comparable?. Heart 89 (2003) 133-138
35. Schwartz R.S., et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 106 (2002) 1867-1873
36. Faraci F.M., et al. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am. J. Physiol. 274 2 Pt 2 (1998) H564-H570
37. Lindner V., et al. Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model. Am. J. Pathol. 148 (1996) 427-438
38. Napoli C., et al. Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U S A 98 (2001) 2860-2864
39. Chadjichristos C.E., et al. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113 (2006) 2835-2843
40. Ali Z.A., et al. Increased in-stent stenosis in ApoE-knockout mice: A novel mouse model of angioplasty and stenting. J. Am. Coll. Cardiol. 47 Suppl. 2 (2006) 23B
41. Migliavacca F., et al. A predictive study of the mechanical behaviour of coronary stents by computer modelling. Med. Eng. Phys. 27 (2005) 13-18
42. Gourisankaran V., et al. The finite element analysis of stresses in atherosclerotic arteries during balloon angioplasty. Crit. Rev. Biomed. Eng. 28 (2000) 47-51
43. Holzapfel G.A., et al. A layer-specific three-dimensional model for the simulation of balloon angioplasty using magnetic resonance imaging and mechanical testing. Ann. Biomed. Eng. 30 (2002) 753-767
44. Rogers C., et al. Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation 94 (1996) 2909-2914
45. Garasic J.M., et al. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 101 (2000) 812-818
46. LaDisa Jr. J.F., et al. Three-dimensional computational fluid dynamics modelling of alterations in coronary wall shear stress produced by stent implantation. Ann. Biomed. Eng. 31 (2003) 972-980
47. Sakakibara M., et al. Application of ex vivo flow chamber system for assessment of stent thrombosis. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1360-1364
48. Barth K.H. Prototype stent in canine iliac arteries. J. Vasc. Interv. Radiol. 7 (1996) 948-949
49. Robinson K.A., et al. Long-term intracoronary stent placement: arteriographic and histologic results after 7 years in a dog model. Cathet. Cardiovasc. Diagn. 38 (1996) 32-37
50. Tortoriello A., et al. Flow-tissue interaction with compliance mismatch in a model stented artery. J. Biomech. 37 (2004) 1-11